In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children

Edwards, Kathryn M.; Snyder, Paula N.; Thompson, Juliette; Johnson, Philip R.; Wright, Peter F.

doi:10.1016/0264-410x(86)90097-6

Cited by 8 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The most profound defence against influenza is provided by adaptive immunity that is mediated by neutralizing strain-specific “seasonal” antibodies directed against highly variable naïve antigens of an infecting influenza. But this is a post-emergent process that optimally takes weeks to months for full development (Murphy et al, 1982; Couch and Kasel, 1983; Edwards et al, 1986), and consequently beyond the time-frame of primary infection, viral shedding and disease development and is incapable of protecting against the first appearance of a new influenza strain. Therefore, additional mechanisms of protection need to be invoked to explain the mass herd immune protection of the community.…”

Section: Introductionmentioning

confidence: 99%

Acquired heterosubtypic antibodies in human immunity for avian H5N1 influenza

Selleck¹

2009

J Mol Genet Med

View full text Add to dashboard Cite

Well understood are the adaptive and dramatic neutralizing homosubtypic antibody responses to hypervariable, immunodominant sites of the hemagglutinin (HA) and neuraminidase (NA) of individual influenza strains. These define influenza subtypes and vaccines modelled upon their HA and NA antigens provide seasonal neutralizing antibody protection against subsequent exposure to the strain and its close relatives, but give little if any protection against antigenically drifted or shifted strains. Contrasting to this is a different form of acquired antibody response, called heterosubtypic immunity. This provides a more seasoned adaptive antibody response to immune-recessive epitopes that are highly-conserved amongst strains. Although, such responses are of lower individual amplitudes than seasonal mechanisms they are active across influenza subtypes, and may give pre-emptive protection against new strains yet to emerge. Heterosubtypic immunities have been well studied in animals, but surprisingly there is minimal evidence for this type of antibody immunity in humans. Thus championed is the notion that seasoned humoral responses can through repeated exposure to sites widely conserved across different strains, cumulatively provide humans with a level of broad protection against emergent novel strains, such as H5N1, that is not afforded by seasonal humoral responses.

show abstract

Section: Introductionmentioning

confidence: 99%